Cataracts are the leading cause of blindness worldwide. Obesity, a key component of metabolic syndrome (MetS), may represent a modifiable risk factor for cataracts. However, the evidence regarding the association between MetS or its components and cataracts remains controversial. Therefore, our meta-analysis aims to clarify the relationship between MetS or its components and cataracts. A search was conducted until February 2024 via the MEDLINE, EMBASE, and Cochrane databases. The primary endpoint included the association between MetS or its components, including body mass index (BMI), diabetes mellitus (DM), hypertension (HT), and dyslipidemia (DLP), and cataracts. Secondary endpoints included the association between levels of blood pressure, blood sugar, and lipid profiles and cataracts. A total of 27 studies were included with a total of 1,010,014 patients (134,498 with cataracts and 875,516 without cataracts). Of these, there were 2 prospective cohort studies, 6 case–control studies, and 19 cross-sectional studies. The prevalence of cataracts was 13.3%. MetS was significantly associated with cataracts with an odds ratio (OR) of 1.60 (95% confidence interval [CI]: 1.44–1.77, I2 = 93%). Among MetS components, high BMI and being diagnosed with DM, HT, and DLP were associated with cataracts with ORs of 1.45 (95% CI: 1.33–1.58, I2 = 80%), 1.77 (95% CI: 1.69–1.85, I2 = 51%), 1.23 (95% CI: 1.19–1.28, I2 = 62%), and 1.38 (95% CI: 1.30–1.46, I2 = 0%). Among the metabolic parameters, high total cholesterol, high triglycerides, low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol were associated with cataracts with ORs of 1.25 (95% CI: 1.04–1.49, I2 = 48%), 1.05 (95% CI: 1.04–1.06, I2 = 68%), 1.07 (95% CI: 1.01–1.13, I2 = 0%), and 1.30 (95% CI: 1.10–1.53, I2 = 71%), respectively. MetS, obesity, DM, HT, and DLP are associated with cataracts. Prevention or treatment of MetS or its components likely represent a modifiable risk factor in cataract development.
BourneR, SteinmetzJD, FlaxmanS, et al.Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study. Lancet Glob Health, 2021; 9(2):e130–e143; doi: 10.1016/S2214-109X(20)30425-3
2.
CicinelliMV, BuchanJC, NicholsonM, et al.Cataracts. Lancet, 2023; 401(10374):377–389; doi: 10.1016/S0140-6736(22)01839-6
3.
NealeRE, PurdieJL, HirstLW, et al.Sun exposure as a risk factor for nuclear cataract. Epidemiology, 2003; 14(6):707–712; doi: 10.1097/01.ede.0000086881.84657.98
4.
WangW, ZhangX. Alcohol intake and the risk of age-related cataracts: A meta-analysis of prospective cohort studies. PLoS One, 2014; 9(9):e107820; doi: 10.1371/journal.pone.0107820
5.
YeJ, HeJ, WangC, et al.Smoking and risk of age-related cataract: A meta-analysis. Invest Ophthalmol Vis Sci, 2012; 53(7):3885–3895; doi: 10.1167/iovs.12-9820
6.
YuanS, WolkA, LarssonSC. Metabolic and lifestyle factors in relation to senile cataract: A Mendelian randomization study. Sci Rep, 2022; 12(1):409; doi: 10.1038/s41598-021-04515-x
7.
PitliyaA, KakarlapudiY, VasudevanSS, et al.The global prevalence of metabolic syndrome in connection with sleep duration: A systematic review and meta-analysis. Metab Syndr Relat Disord, 2024; 22(6):411–421; doi: 10.1089/met.2024.0004
8.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285(19):2486–2497; doi: 10.1001/jama.285.19.2486
9.
GrundySM, BrewerHBJr, CleemanJI, et al.; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 2004; 109(3):433–438; doi: 10.1161/01.CIR.0000111245.75752.C6
10.
PanC-W, LinY. Overweight, obesity, and age-related cataract: A meta-analysis. Optom Vis Sci, 2014; 91(5):478–483; doi: 10.1097/OPX.0000000000000243
11.
TanAG, KifleyA, FloodVM, et al.Evaluating the associations between obesity and age-related cataract: A Mendelian randomization study. Am J Clin Nutr, 2019; 110(4):969–976; doi: 10.1093/ajcn/nqz167
12.
JiangC, MellesRB, SanganiP, et al.Association of behavioral and clinical risk factors with cataract: A two-sample Mendelian Randomization Study. Invest Ophthalmol Vis Sci, 2023; 64(10):19; doi: 10.1167/iovs.64.10.19
13.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010; 25(9):603–605; doi: 10.1007/s10654-010-9491-z
14.
GaleoneC, PetracciE, PelucchiC, et al.Metabolic syndrome, its components and risk of age-related cataract extraction: A case-control study in Italy. Ann Epidemiol, 2010; 20(5):380–384; doi: 10.1016/j.annepidem.2010.01.009
15.
PaunksnisA, BojarskieneF, CimbalasA, et al.Relation between cataract and metabolic syndrome and its components. Eur J Ophthalmol, 2007; 17(4):605–614; doi: 10.1177/112067210701700420
16.
RimTH, KimMH, KimWC, et al.Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008–2010. BMC Ophthalmol, 2014; 14:4; doi: 10.1186/1471-2415-14-4
17.
ParkS, LeeEH. Association between metabolic syndrome and age-related cataract. Int J Ophthalmol, 2015; 8(4):804–811; doi: 10.3980/j.issn.2222-3959.2015.04.29
18.
SabanayagamC, WangJJ, MitchellP, et al.Metabolic syndrome components and age-related cataract: The Singapore Malay eye study. Invest Ophthalmol Vis Sci, 2011; 52(5):2397–2404; doi: 10.1167/iovs.10-6373
19.
AthanasiovPA, CassonRJ, SullivanT, et al.Cataract in rural Myanmar: Prevalence and risk factors from the meiktila eye study. Br J Ophthalmol, 2008; 92(9):1169–1174; doi: 10.1136/bjo.2008.139725
20.
AthanasiovPA, EdussuriyaK, SenaratneT, et al.Cataract in central Sri Lanka: Prevalence and risk factors from the Kandy Eye Study. Ophthalmic Epidemiol, 2010; 17(1):34–40; doi: 10.3109/09286580903324900
21.
LimLS, TaiES, AungT, et al.Relation of age-related cataract with obesity and obesity genes in an Asian population. Am J Epidemiol, 2009; 169(10):1267–1274; doi: 10.1093/aje/kwp045
22.
LuZQ, SunWH, YanJ, et al.Cigarette smoking, body mass index associated with the risks of age-related cataract in male patients in northeast China. Int J Ophthalmol, 2012; 5(3):317–322; doi: 10.3980/j.issn.2222-3959.2012.03.13
23.
RamanR, PalSS, AdamsJS, et al.Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Invest Ophthalmol Vis Sci, 2010; 51(12):6253–6261; doi: 10.1167/iovs.10-5414
24.
ShahSP, DineenB, JadoonZ, et al.Lens opacities in adults in Pakistan: Prevalence and risk factors. Ophthalmic Epidemiol, 2007; 14(6):381–389; doi: 10.1080/09286580701375179
25.
TavaniA, NegriE, La VecchiaC. Selected diseases and risk of cataract in women. A case-control study from Northern Italy. Ann Epidemiol, 1995; 5(3):234–238; doi: 10.1016/1047-2797(94)00111-6
26.
FosterPJ, WongTY, MachinD, et al.Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: The Tanjong Pagar Survey. Br J Ophthalmol, 2003; 87(9):1112–1120; doi: 10.1136/bjo.87.9.1112
27.
KimTN, LeeJE, LeeEJ, et al.Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: The 2008-2009 Korea National Health and Nutrition Examination Survey. PLoS One, 2014; 9(4):e94189; doi: 10.1371/journal.pone.0094189
28.
RimTH, KimDW, KimSE, et al.Factors associated with cataract in Korea: A Community Health Survey 2008-2012. Yonsei Med J, 2015; 56(6):1663–1670; doi: 10.3349/ymj.2015.56.6.1663
29.
UghadeSN, ZodpeySP, KhanolkarVA. Risk factors for cataract: A case control study. Indian J Ophthalmol, 1998; 46(4):221–227.
30.
ChangJH, ChenIH, GengJH, et al.Metabolic syndrome is associated with cataract in a large taiwanese population study. Nutrients, 2022; 14(9):1684; doi: 10.3390/nu14091684
31.
HeydariB, KazemiT, ZarbanA, et al.Correlation of cataract with serum lipids, glucose and antioxidant activities: A case-control study. West Indian Med J, 2012; 61(3):230–234; doi: 10.7727/wimj.2011.103
32.
LiS, LiD, ZhangY, et al.Association between serum lipids concentration and patients with age-related cataract in China: A cross-sectional, case-control study. BMJ Open, 2018; 8(4):e021496; doi: 10.1136/bmjopen-2018-021496
33.
TomićM, VrabecR, RaštegoracP, et al.Hypertension and hypercholesterolemia are associated with cataract development in patients with type 2 diabetes. High Blood Press Cardiovasc Prev, 2021; 28(5):475–481; doi: 10.1007/s40292-021-00472-8
34.
TungTH, LiuJH, LeeFL, et al.Community-based study of cataracts among type 2 diabetics in Kinmen. Eur J Epidemiol, 2005; 20(5):435–441; doi: 10.1007/s10654-004-7537-9
35.
TangY, WangX, WangJ, et al.Risk factors of age-related cataract in a Chinese adult population: The Taizhou Eye Study. Clin Exp Ophthalmol, 2018; 46(4):371–379; doi: 10.1111/ceo.13040
36.
ParkS, KimT, ChoSI, et al.Association between cataract and the degree of obesity. Optom Vis Sci, 2013; 90(9):1019–1027; doi: 10.1097/OPX.0b013e31829cae62
37.
ParkYH, ShinJA, HanK, et al.Gender difference in the association of metabolic syndrome and its components with age-related cataract: The Korea National Health and Nutrition Examination Survey 2008-2010. PLoS One, 2014; 9(1):e85068; doi: 10.1371/journal.pone.0085068
38.
LeskeMC, WuSY, HennisA, et al.Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology, 1999; 106(1):35–41; doi: 10.1016/s0161-6420(99)90003-9
39.
Phaswana-MafuyaN, PeltzerK, CrampinA, et al.Prevalence of self-reported diagnosed cataract and associated risk factors among elderly South Africans. Int J Environ Res Public Health, 2017; 14(12):1523; doi: 10.3390/ijerph14121523
40.
YoshidaM, InoueM, IwasakiM, et al.; JPHC Study Group. Association of body mass index with risk of age-related cataracts in a middle-aged Japanese population: The JPHC Study. Environ Health Prev Med, 2010; 15(6):367–373; doi: 10.1007/s12199-010-0153-2
41.
KahnR, BuseJ, FerranniniE, et al.; European Association for the Study of Diabetes. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2005; 28(9):2289–2304; doi: 10.2337/diacare.28.9.2289
42.
Ng Yin LingC, LimSC, JonasJB, et al.Obesity and risk of age-related eye diseases: A systematic review of prospective population-based studies. Int J Obes (Lond), 2021; 45(9):1863–1885; doi: 10.1038/s41366-021-00829-y
43.
NiaziS, MoshirfarM, DastjerdiMH, et al.Association between obesity and age-related cataract: An updated systematic review and dose-response meta-analysis of prospective cohort studies. Front Nutr, 2023; 10:1215212; doi: 10.3389/fnut.2023.1215212
44.
TanAG, ThamYC, CheeML, et al.Incidence, progression and risk factors of age-related cataract in Malays: The Singapore Malay Eye Study. Clin Exp Ophthalmol, 2020; 48(5):580–592; doi: 10.1111/ceo.13757
45.
ReddyPY, GiridharanNV, ReddyGB. Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. Mol Vis, 2012; 18:495–503; doi: 10.4081/ejcm.2012.v3.e80
46.
StevensVJ, RouzerCA, MonnierVM, et al.Diabetic cataract formation: Potential role of glycosylation of lens crystallins. Proc Natl Acad Sci U S A, 1978; 75(6):2918–2922; doi: 10.1073/pnas.75.6.2918
47.
BetzlerBK, RimTH, SabanayagamC, et al.High-density lipoprotein cholesterol in age-related ocular diseases. Biomolecules, 2020; 10(4):645; doi: 10.3390/biom10040645
48.
ThompsonA, FleischmannKE, SmilowitzNR, et al.2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery: A Report of the American College of. Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2024; 84(19):1869–1969.
49.
KangC, LeeMJ, ChomskyA, et al.Risk factors for complications in resident-performed cataract surgery: A systematic review. Surv Ophthalmol, 2024; 69(4):638–645; doi: 10.1016/j.survophthal.2024.04.002
50.
ChenCL, LinGA, BardachNS, et al.Preoperative medical testing in Medicare patients undergoing cataract surgery. N Engl J Med, 2015; 372(16):1530–1538; doi: 10.1056/NEJMsa1410846
VandanmagsarB, YoumYH, RavussinA, et al.The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med, 2011; 17(2):179–188; doi: 10.1038/nm.2279
53.
KohKK, HanSH, QuonMJ. Inflammatory markers and the metabolic syndrome: Insights from therapeutic interventions. J Am Coll Cardiol, 2005; 46(11):1978–1985; doi: 10.1016/j.jacc.2005.06.082
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
